Program
TAK-951
A development code.
Its studies are mostly in Nausea · Postoperative Nausea and Vomiting, led by Takeda.
Furthest: phase 2, since Sep 18, 20205 company-led studies, 0 open or running
Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| Takeda | 50 open or running | phase 2since Sep 18, 2020 | Jul 22, 2020 | none ahead |
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
- Jul 22, 2020First study: phase 1 study in Healthy VolunteerFirst studyNCT04486950 · 32 enrolled · United States
- Sep 18, 2020Phase 2 study in Postoperative Nausea and VomitingNCT04557189 · 89 enrolled · United States
- Oct 25, 2021Phase 1 study in Healthy VolunteersNCT05567393 · 128 enrolled · United States
- Sep 21, 2024Phase 1 study in Healthy VolunteersNCT06610279 · 48 enrolled · United States
- Jan 6, 2025Phase 1 study in NauseaNCT06768658 · 1 enrolled · United States
TargetBeta
Not stated by its company or a source we have read. Most early programs say nothing of it.
Studies
All 5 led by companies developing it, newest first. Each opens its study page.
| Study | Phase | Status | Primary completion | Size |
|---|---|---|---|---|
| NCT06768658Nausea · United States | 1 | Terminated | Jan 9, 2023 | 1 |
| NCT06610279Healthy Volunteers · United States | 1 | Terminated | Sep 21, 2023 | 48 |
| NCT05567393Healthy Volunteers · United States | 1 | Completed | Nov 2, 2020 | 128 |
| NCT04557189Postoperative Nausea and Vomiting · United States | 2 | Completed | Mar 7, 2022 | 89 |
| NCT04486950Healthy Volunteer · United States | 1 | Completed | May 16, 2021 | 32 |
How it is read
Names in the registry
- “TAK-951”, 5 entries
Codes read as this program: TAK951.
Conditions, from the studies’ own filings
- Nausea, 1 study
- Postoperative Nausea and Vomiting, 1 study
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.